Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Gains from Investment Securities: 2018-2024

Historic Gains from Investment Securities for IDEAYA Biosciences (IDYA) over the last 7 years, with Dec 2024 value amounting to $32.0 million.

  • IDEAYA Biosciences' Gains from Investment Securities fell 57.34% to $6.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $23.7 million, marking a year-over-year decrease of 23.10%. This contributed to the annual value of $32.0 million for FY2024, which is 89.35% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Gains from Investment Securities stood at $32.0 million for FY2024, which was up 89.35% from $16.9 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Gains from Investment Securities registered a high of $32.0 million during FY2024, and its lowest value of $4,000 during FY2021.
  • Its 3-year average for Gains from Investment Securities is $16.9 million, with a median of $16.9 million in 2023.
  • Per our database at Business Quant, IDEAYA Biosciences' Gains from Investment Securities tumbled by 99.66% in 2021 and then spiked by 44,900.00% in 2022.
  • Over the past 5 years, IDEAYA Biosciences' Gains from Investment Securities (Yearly) stood at $1.2 million in 2020, then slumped by 99.66% to $4,000 in 2021, then surged by 44,900.00% to $1.8 million in 2022, then surged by 838.89% to $16.9 million in 2023, then skyrocketed by 89.35% to $32.0 million in 2024.